Related Experiment Video
Updated: Jan 30, 2026

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Statin Toxicity
Natalie C Ward1,2, Gerald F Watts2,3, Robert H Eckel4
1From the School of Public Health, Curtin University, Perth, Western Australia, Australia (N.C.W.).
Insights
Lowering LDL cholesterol with statins significantly reduces cardiovascular risk. However, statin-associated muscle symptoms often lead to discontinuation, highlighting the need for alternative strategies and risk identification.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Background:
- Lowering low-density lipoprotein cholesterol (LDL-c) is crucial for reducing cardiovascular morbidity and mortality.
- Statins are widely prescribed for cholesterol management but face challenges with patient adherence and discontinuation.
- Statin-associated muscle symptoms (SAMS) are a primary reason for treatment cessation, impacting atherosclerotic cardiovascular disease prevention.
Purpose of the Study:
- To review the mechanisms and clinical significance of statin toxicity.
- To focus on the evaluation and management of statin-associated muscle symptoms.
- To identify individuals at higher risk for statin side effects and explore alternative treatments.
Main Methods:
- Literature review of statin mechanisms, toxicity, and side effects.
- Analysis of clinical importance and patient adherence data.
- Focus on diagnostic and therapeutic strategies for statin-induced muscle symptoms.
Main Results:
- Overwhelming evidence supports LDL-c lowering for cardiovascular risk reduction.
- Statin discontinuation due to side effects, particularly muscle symptoms, remains a significant barrier.
- Understanding and managing statin toxicity is essential for effective cardiovascular disease prevention.
Conclusions:
- Effective LDL-c reduction is vital for cardiovascular health.
- Addressing statin-associated muscle symptoms is critical for improving adherence and treatment outcomes.
- Further research into mechanisms and alternative therapies is needed to optimize statin use.
Abstract:
There is now overwhelming evidence to support lowering LDL-c (low-density lipoprotein cholesterol) to reduce cardiovascular morbidity and mortality. Statins are a class of drugs frequently prescribed to lower cholesterol. However, in spite of their wide-spread use, discontinuation and nonadherence remains a major gap in both the primary and secondary prevention of atherosclerotic cardiovascular disease. The major reason for statin discontinuation is because of the development of statin-associated muscle symptoms, but a range of other statin-induced side effects also exist. Although the mechanisms behind these side effects have not been fully elucidated, there is an urgent need to identify those at increased risk of developing side effects as well as provide alternative treatment strategies. In this article, we review the mechanisms and clinical importance of statin toxicity and focus on the evaluation and management of statin-associated muscle symptoms.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Frequency-dependent Selection
Predator-Prey Interactions
Responses to Salt Stress
Comparative Excretory Systems

